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Curcumin (CUR) and fish oil (FO) are among the most well-known types of natural anti-inflammatory compounds.
The aim of this study was to assess the effect of nanocurcumin and fish oil vs. glucocorticoids on Holstein calves’
health status. A lipopolysaccharide (LPS) challenge (0.5 μg kg1 BW) was used to induce an acute phase response.
A total of 42 male Holstein calves were randomized into 7 groups: negative control (CON), positive control (LPS,
injected once), 250 mg/kg BW per day fish oil þ LPS (FO250), 350 mg/kg BW per day fish oil þ LPS (FO350), 2
mg/kg BW per day nanocurcumin þ LPS (NCUR2), 4 mg/kg BW per day nanocurcumin þ LPS (NCUR4), and 0.3
mg/kg BW dexamethasone (injected once) þ LPS (DEX). The duration of this experiment was 11 days, with
application of the LPS challenge on day 8. Calves were weighed on days 0, 7, 9, 10, and 11 to record the average
daily weight gain; diets offered and refused were recorded daily throughout the experiment. Blood collection and
clinical scoring were conducted at successive time points until 72 h post LPS challenge. The data obtained also
comprised rectal temperature (RT), respiratory rate (RR), heart rate (HR), concentrations of tumor necrosis factor-
α (TNF-α), interleukin 6 (IL-6), serum amyloid A (SAA), and haptoglobin (Hp). This experiment could not uncover
significant effects of LPS, FO, NCUR, and DEX on the area under the curve (AUC) of the RT, HR, and RR; in
addition, there was no difference between FO and NCUR vs. LPS in sickness behavior, however, DEX group
significantly recovered faster than others (P < 0.01). There was no significant difference between groups in dry
matter intake (DMI) and average daily gain (ADG) during three days post LPS challenge. The concentrations of
TNF-⍺, IL-6, and SAA were lower in the DEX group (P < 0.05). Finally, no effects of FO and NCUR on cytokines
and acute phase proteins (APPs) could be observed in this study. In conclusion, supplementation of FO and NCUR
was not able to impact the acute phase response (APR) in calves, as levels of inflammatory cytokines and APPs as
well as sickness behavior remained unchanged. It seems that the anti-inflammatory effects of FO and CUR on APR,
as has been observed for other animal species, do not manifest that clearly in calves.1. Introduction
The use of complementary and alternative medicines (CAM) as a
substitute or supplement to conventional medicines has grown consid-
erably over the past decades in human society (Koning et al., 2013).
Popular CAM therapies comprise herbs (including Chinese medicines,
curcumin, and cannabis), probiotics, vitamins, and fish oil (Cheifetz
et al., 2017). Additionally, CAM has long been employed in traditional
animal medicine and as a feed supplement to livestock diets (Oh et al.,be (S. Kamel Oroumieh), Naseria
form 17 November 2020; Accept
vier Ltd. This is an open access ar2013). Antimicrobial activities, immune enhancement, and stress
reduction are the most useful properties attributed to different CAM
compounds in animals (Oh et al., 2013). Among CAM, curcumin (CUR)
and fish oil (FO) are two well-known anti-inflammatory compounds
whose mechanisms of anti-inflammatory action are remarkably compa-
rable to that of glucocorticoids (Rhen and Cidlowski, 2005; Calder, 2013;
Prasad et al., 2014).
Curcumin is the primary active component of turmeric, a yellow
compound originally isolated from the plant Curcuma longa, havingn@um.ac.ir (A.A. Naserian).
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2007). This component has been widely investigated as an
anti-inflammatory compound in rodents and pigs. Studies evidenced that
CUR improved the anti-inflammatory response to lipopolysaccharide
(LPS) challenge by a significant decrease in pro-inflammatory cytokines
such as TNF-α (Yun et al., 2010; Liu, 2012; Bible, 2013). Nevertheless,
the poor bioavailability of CUR is one of its major drawbacks (Prasad
et al., 2014). Most studies revealed that formulated CUR (such as nano-
particles) had better bioavailability and biological activities than its
unformulated counterpart (Sun et al., 2010; Ahmadi et al., 2018; Hata-
mipour et al., 2019). Surprisingly, there is still a lack of knowledge on the
effect of CUR and especially nanocurcumin (NCUR) as anti-inflammatory
CAM compound in ruminants.
Fish oil has been extensively documented in both human and animal
research, confirming its beneficial anti-inflammatory effects as a marine
n-3 polyunsaturated fatty acids (PUFA) source (Ballou et al., 2008;
Calder, 2013). Gandra et al. (2016) demonstrated that dairy cows fed an
n-3 FA source had higher expression of T helper cells (CD4þ) and
potentially greater pro-inflammatory actions than cows fed an n-6 FA
source. Ballou et al. (2008) and Greco et al. (2015) reported that n-3
PUFA could modulate the inflammatory response following LPS chal-
lenge in ruminants. Feeding diets containing n-3 FA may be beneficial for
calf health, as it alters the cytokine response and regulation of the in-
flammatory response, hence affecting the ability of the animal to respond
to disease. However, there is a lack of information regarding the effect of
n-3 PUFA vs. other CAM or anti-inflammatory drugs on calves.
Although corticosteroids have an immunosuppressive effect, they
have a substantial short-term effect on the acute phase response (APR) in
ruminants through inhibiting the release of pro-inflammatory cytokines,
supporting their popularity as a drug to treat acute inflammatory pro-
cesses in cattle (Lekeux and VandeWeerdt, 1997). Among corticosteroids,
dexamethasone (DEX) has an approved inhibitory effect on LPS-induced
TNF-α serum levels in calves. In the studie of Ohtsuka et al. (1997) and
Plessers et al. (2015a), pretreatment of DEX (0.3 mg/kg BW) significantly
decreased the TNF-α concentration and endotoxin shock in LPS chal-
lenged calves. Therefore, using DEX as a positive control immunomod-
ulatory drug in LPS challenged calves, allows to evaluate the effects of
other anti-inflammatory compounds. Besides, in the current study, an
LPS model introduced by Plessers et al. (2015b) was applied to induce
APR in calves.
This research aimed at investigating the effect of nanocurcumin and
fish oil as natural anti-inflammatory compounds vs.DEX in response to an
LPS challenge in calves. Not only is this experiment the first to evaluate
the effect of NCUR in response to an LPS challenge in calves, but it is also
the first report which compared FO and NCUR vs. DEX under LPS chal-
lenge in ruminants. This research contained two hypotheses: (1) FO and
NCUR could significantly inhibit the increase of inflammatory cytokines
and APPs through APR in calves. (2) FO and NCUR as an adequate
alternative to glucocorticoids could decrease the high demand for drugs
to treat calves’ diseases.
2. Materials and methods
The experiment was conducted at the dairy farm facilities of AQR
Animal Husbandry and Agriculture Co. (Mashhad, Iran) in February
2019. The ethics committee of the Ferdowsi University of Mashhad, Iran
approved all experimental procedures and animal manipulations (IACUC
#A47228) based on the Iranian Council of Animal Care.
2.1. Calves, treatments, and study protocol
A total of 42 male Holstein calves, with a mean age of 34.9 (3.6)
days and average body weight 55.3 (4.2) kg, were randomly housed
outdoors in 1  2 m individual pens at ambient temperature (approxi-
mately 11 C). The interior of each pen was bedded with wheat straw,
which was renewed every 24 h. The sample size and practical setup2
mimicked that as proposed by Plessers et al. (2015a and 2015b). The
summary of the experimental process is illustrated in Figure 1. The
duration of the experiment was 11 days (Figure 1, days 1–11) with an
acclimatization period of 7 days (Figure 1, days -7 to 0). One day before
the start of the experiment (Figure 1, day 0), calves were weighed, and
randomly divided into seven groups with six replicates per group and
treated with 5 mg kg1 BW enrofloxacin (RazakPharma Co., Tehran,
Iran), to avoid unexpected respiratory infections. The following seven
experimental groups were included: 1. negative control (CON, the group
which was subjected neither to LPS nor to other treatments), 2. positive
control (LPS, injected once), 3. 250 mg/kg BW per day fish oil þ LPS
(FO250), 4. 350 mg/kg BW per day fish oil þ LPS (FO350), 5. 2 mg/kg
BW per day nanocurcumin þ LPS (NCUR2), 6. 4 mg/kg BW. Per day
nanocurcumin þ LPS (NCUR4), and 7. 0.3 mg/kg BW Dexamethasone þ
LPS (DEX, injected once). Regarding LPS, DEX, FO and CUR, the doses as
reported by Plessers et al. (2015b), Ohtsuka et al. (1997), Litherland et al.
(2010), and Bible (2013), were administered, respectively. All calves
received a total of 5 L of whole milk twice a day. In order to ensure that
FO and NCUR passed the rumen, the compounds were mixed with the
whole milk that was offered. Twenty-fivemg of vitamin E.kg1 PUFAwas
added to the milk to avoid the incidence of muscular dystrophy. All
groups received the same diet, based on NRC (2001) recommendations,
which contained a mixture of starter and chopped alfalfa hay (Table 1).
Animals had free access to freshwater. According to the groups, FO (Kilka
oil, Parskilka Sea Products Co., Mazandaran, Iran) and NCUR were used
from day 1 until the end of the experiment (Figure 1). To increase the oral
bioavailability of CUR, NCUR oral capsules (SinaCurcumin, Exir Nano,
Tehran, Iran) were used, which are a registered product from curcumi-
noids (IRC: 1228225765). Its bioavailability and stability have been
confirmed in previous experiments (Ahmadi et al., 2018; Hatamipour
et al., 2019). From the acclimatization period until the LPS challenge
(Figure 1, days -7 to 8), the animals’ clinical status was assessed once a
day, including measurement of the rectal body temperature (RT), respi-
ratory rate (RR), heart rate (HR), and visual inspection of feces. There
was no record of diarrhea or any specific illness during the experiment.
One day before the LPS challenge (Figure 1, day 7), calves were weighed
again, following a 16 G indwelling catheter located aseptically in the
right jugular vein. One hour before the LPS challenge (Figure 1, day 8,
time -1), the clinical status was assessed by determination of the RT and
visual investigation of the feces. An RT  39.5 C was chosen as an
elimination criterion for the experiment at this time.
Except for the CON group, the other experimental groups were
intravenously challenged once with 0.5 μg kg1 BW ultrapure LPS from
E. coli serotype O111:B4 (Sigma–Aldrich®; product NO. L2630). The
CON group received a similar volume of saline solution. One hour before
the LPS challenge, the calves in group DEXwere treated once with 0.3 mg
kg1 BW DEX (Aburaihan Pharmaceutical Co., Tehran, Iran) intramus-
cularly in the neck region (cervical ventral serratus muscle) to obtain the
maximum influence of the drug on the innate immune response. In order
to investigate the reference level of cytokines and APPs, venous blood
samples were collected from the catheter one hour before the LPS chal-
lenges (Figure 1, day 8, time -1, before DEX treatment), and transferred
into EDTA-containing tubes. To evaluate cytokines and APPs in inflam-
matory condition, blood samples were collected at 1, 2, 3, 4, 6, 12, 24, 48,
72 h, post LPS challenge (p.c.). RT, RR, and HR were recorded at 0.5, 1,
1.5, 2, 2.5, 3, 4, 5, 6, 8, 12, 18, 24 h p.c (Figure 1). First, RR was
measured; subsequently, we entered the pens to determine RT by using a
digital thermometer and HR as well.
Once the LPS challenge was performed, animals were clinically
scored by two qualified veterinarians during 18 h. During this time,
dyspnoea, coughing, breathing sounds, mental state, position, and
appetite were evaluated. According to these parameters, the appearance
of behavioral phases (respiratory, depression, and recovery phase) was
evaluated (Figure 3) with the model detailed in Plessers et al. (2015b).
Whenever calves exposed systemic shock symptoms, they would be hu-
manely slaughtered. The retrieved blood samples were centrifuged at
Figure 1. Schematic diagram of the experimental procedure.
Table 1. Ingredients and nutrient composition of the diet.
Item Value
Ingredients %




Corn gluten meal 1.8
Wheat bran 6.5






DM, % as fed 90
CP, % DM 19.5
NDF, % DM 17
ADF, % DM 9.1
Ether extract, % DM 3
Ca, % DM 0.7
P, % DM 0.5
Calculated ME,2 Mcal/kg of DM 3.15
1 Contained per kilogram of supplement: 250,000 IU of vitamin A, 50,000 IU of
vitamin D, 1,500 IU of vitamin E, 120 g of Ca, 20 g of P, 20.5 g of Mg, 186 g of Na,
7.7 g of Zn, 2.25 g of Mn, 1.25 g of Fe, 3 g of S, 14 mg of Co, 1.25 g of Cu, 56 mg of
I, and 10 mg of Se.
2 Metabolizable energy using NRC (2001) equations.
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aliquots at   80 C until analysis. In order to assess the effect of
treatments on average daily gain (ADG) and dry matter intake (DMI),
calves were weighed on days 0, 7, 9, 10, 11, and the amount of starter
diets offered and refused was recorded daily throughout the experiment
(Figure 5).
2.2. Sample analyses for cytokines and acute phase proteins
In order to identify and quantify cytokines and APPs, plasma samples
were analyzed in duplicate, using commercially available ELISA kits
(Bioassay Technology Laboratory ELISA kits, Shanghai, China; Cat No.
E0019BO, No. E0001BO, No. E0022BO, and No. E0023BO for TNF-α, IL-
6, Hp, and SAA, respectively). Plasma samples were prediluted 10-fold
for TNF-α, 10-fold for IL-6, and 20-fold for SAA measurements. The cy-
tokines and APPs assays were performed according to the manufacture's
protocol, resulting in intra-assay CVs of TNF-α, IL-6, Hp, and SAA of 9.66,
9.32, 8.70, and 9.15%, respectively. The analytical sensitivities of these
tests in plasma have been determined by the manufacturer as 5.85 pg
ml1, 10.50 pg ml1, 0.054 μg ml1, and 1.36 μg ml1, for TNFα, IL-6,
SAA, and Hp, respectively.
2.3. Statistical analysis
Data were checked for normal distribution, and non-normal data
were analyzed using a Kruskal-Wallis test. To evaluate the effect of LPS
within the different groups, the repeated-measures ANOVA was per-
formed. Data were analyzed completely randomized with the fixed effect
of treatment, time and interaction between treatment and time, as well as
the random effect of calf nested within treatment by using JMP (13.2)
software. The area under the curve (AUC) for RR (0–6), RT (0–24), HR
(0–24), TNF-⍺ (0–4), IL-6 (0–6), SAA (0–72), and Hp (0–24) indicated the
diagnostic accuracy of the examined parameter (Gardner and Greiner,
2006). Lastly, the treatment's significance was determined by the
LSMEANS Tukey HSD test. All values were expressed as mean and
standard deviation (SD), and P < 0.05 was considered as statistically
significant. To investigate the factors that might influence AUC (RT, HR,
RR, cytokines, and acute phase proteins), DMI, and ADG responses, a full
factorial linear regression analysis was performed by using JMP (13.2)
software. The individual factors (BW, DMI, age, and groups) were sub-
jected to the backward stepwise selection process, and a significance
level of P < 0.05 was used as a selection criterion. The DMI and BW
factors were excluded from DMI and ADG models, respectively.
3. Results
3.1. Clinical signs, DMI, and ADG
The final number of calves that could be used for analysis was the
following: n ¼ 6 CON, n ¼ 6 LPS, n ¼ 5 FO250, n ¼ 6 FO350, n ¼ 5
NCUR2, n ¼ 5 NCUR4, and n ¼ 6 DEX. Because of the occurrence of
severe shock symptoms, one calf was humanely slaughtered (130min p.c.
in NCUR4 groups) whereas two other calves (from the FO250 and
NCUR2 groups) were excluded from the experiment and treated to avoid
the appearance of severe shock symptoms. It is worth to mention that no
negative effects of FO and CUR treatments on calves have been reported3
before, for which the appearance of any shock symptoms is likely to
relate to individual sensitivity of calves to LPS. One hour before the LPS
challenge (Figure 1, day 8, time -1), the average values for RR, RT, and
HR among the different groups were 34.9 5 bpm, 38.6 0.2 C, 75.6
8 bpm, respectively. Except for the CON group, repeated measures
ANOVA revealed a significant effect of time for all parameters within
each group following the LPS challenge (P < 0.05). After 24 h p.c., RT,
HR, and RR returned to the basal level (P > 0.05). Figure 2 presents the
effect of the groups in response to the LPS challenge on clinical param-
eters. In the CON group, there was no substantial difference in RT, HR,
and RR for the entire duration of the experiment. A significant disparity
in RT and HR between CON and other groups was present at 2–18 h p.c.
(P< 0.05), while it was manifested in RR at 0.5–2 h p.c. (P< 0.05). There
was no significant difference in RT between LPS, FO350, NCUR4, and
DEX during the 5–24 h p.c. time interval (Figure 2A), with the exception
of time 3 and 4 h p.c., at which RT in FO350 was significantly lower than
DEX (P < 0.05). No significant difference was observed in HR between
LPS, FO350, NCUR4, and DEX during 4–24 h p.c. (Figure 2B). The RRwas
not significantly different between LPS challenged groups, and clearly
increased in all groups after LPS administration (peak at 1 h p.c.), which
was followed by a swift decline in the subsequent hour (Figure 2C). In
this experiment, there was no significant difference between LPS chal-
lenged groups in the AUC of the RT, HR, and RR (Table 2). Also, no
interaction effects were found between BW, DMI, age, and groups.
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progression of the three consecutive behavioral phases (Figure 3). None
of the calves in LPS, FO, and NCUR exhibited any deviation in diet or
water before the end of the recovery phase. As expected, DEX did not
present a depression phase and had a faster recovery from the challenge.
The incidence of coughing and open-mouth breathing through the res-
piratory phase did not vary between groups. In this study, most calves
were positioned sternally, while lateral decubitus during the respiratory
and depression phases was expressed by 2, 1, 1, 2, and 1 calves in the LPS,
FO250, FO350, NCUR2, and NCUR4 groups, respectively. The calves in
the DEX group recovered faster than the other groups (P < 0.01). Based
on the model of Plessers et al. (2015b), full recovery was recognized in
the LPS, FO250, FO350, NCUR2, NCUR4, and DEX group at a mean time
of 7.2, 7.5, 6.6, 7.5, 6.1 and 3.3 h p.c., respectively. At 12 h p.c., all calves
easily consumed the supplied 2.5 L of milk. In addition, there was no
significant difference in DMI and ADG among all groups during three
days p.c. (Figure 5). No interaction effects between independent factors
were observed.Figure 2. Effects of fish oil and nanocurcumin vs. dexamethasone on rectal tempe
challenge. Data is shown as mean þ SD. The different letters within each time (T) i
4
3.2. Inflammatory mediators
The groups’ responses to the LPS challenge on cytokines and APPs are
presented in Figure 4. The highest concentrations of TNF-⍺, IL-6, SAA,
and Hp were observed at 1, 3, 24, and 24 h p.c., respectively, in all LPS
challenged groups (Figure 4). Compared to the other groups, the DEX
group displayed a significant effect on TNF-⍺ at 1 and 3 h p.c. (P < 0.05).
At 3 h p.c., no difference was observed between FO250, FO350, NCUR4,
and DEX in TNF-⍺. However, the level of IL-6 was significantly lower in
DEX than in other groups (P < 0.01). By contrast, the DEX group showed
the highest level of Hp at 72 h p.c (P< 0.01). Also, a significant difference
between LPS and DEX in SAA was seen at 24 h p.c. (P < 0.05). The AUC
for cytokines was significantly lower in the DEX compared to other
groups (P < 0.01), although no significant difference in APPs was
observed among all groups (Table 2). Besides, there were no interaction
effects between independent factors in the AUC of the cytokines and
APPs.rature (A), heart rate (B), and respiratory rate (C) in Holstein calves after LPS
ndicate a significant difference between groups (P < 0.05).
Table 2. Effect of fish oil and nanocurcumin vs. dexamethasone in response to an LPS challenge on the area under the curve (AUC).
Item Groups1 SEM P-Value
LPS FO250 FO350 NCUR2 NCUR4 DEX
RT2 937.4 940.5 936.1 941.4 937.7 935.3 1.33 0.06
HR3 2364 2636 2424 2635 2493 2300 150.8 0.13
RR4 336.8 344.4 332.8 346.4 329.2 318.6 31.2 0.94
TNF-⍺5 23.9a 23.7a 21.6a 23.4a 20.8a 9.2b 3.70 <0.01
IL-66 57.7a 59.6a 54.3a 59.0a 52.8a 16.9b 8.04 <0.01
Hp7 11.4 12.7 11.6 12.0 11.4 15.1 2.86 0.72
SAA8 19.3 18.3 16.8 17.5 17.2 15.2 3.44 0.72
a,b Means within a row with different superscripts differ (P < 0.01).
1 Groups: LPS ¼ positive control; FO250 ¼ 250 mg/kg BW per day fish oil þ LPS; FO350 ¼ 350 mg/kg BW per day fish oil þ LPS; NCUR2 ¼ 2 mg/kg BW per day
nanocurcumin þ LPS; NCUR4 ¼ 4 mg/kg BW per day nanocurcumin þ LPS; DEX ¼ 0.3 mg/kg BW dexamethasone þ LPS.
2 RT ¼ rectal temperature, AUC0–24h (C  h).
3 HR ¼ heart rate, AUC0–24h (bpm  h).
4 RR ¼ respiratory rate, AUC0–6h (bpm  h).
5 TNF-⍺ ¼ TNF-⍺, AUC0–4h (ng/mL  h).
6 IL-6 ¼ interleukin-6, AUC0–6h (ng/mL  h).
7 Hp ¼ haptoglobin, AUC0–72h (mg/mL  h).
8 SAA ¼ serum amyloid A, AUC0–72h (mg/mL  h).
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In this study, as a first research hypothesis, it was assessed whether
FO and NCUR treatment could significantly inhibit the increase of in-
flammatory cytokines and APPs upon APR in calves. Indeed, both FO and
NCUR have been acknowledged as anti-inflammatory compounds (Jacob
et al., 2007; Calder, 2013), exerting protective effects against inflam-
matory diseases by amongst other the inhibition of the NF-κB protein
complex that is involved in the synthesis of IL-6 and TNF-α (Zhao et al.,
2005). However, in the current study the results indicated no effects for
both treatments on the cytokines and APPs concentration levels,
following LPS challenge.
Although there is limited knowledge about the effect of CUR on the
health status of ruminants, the current findings regarding CUR are in line
with those of Oh et al. (2013), who reported that inflammatory cytokines
(TNF-α, IL-6, and IFN-γ) were not influenced by curcumin (2 g/cow per
day) in an in vitro LPS challenge experiment in dairy cows. The present
study proves that even with a better bioavailability of CUR (using NCUR),
there is still no effect of CUR on cytokines concentrations in calves. The5
current research was contradictory to the findings of Xun et al. (2015),
who uncovered that 300 or 400 mg/kg DM CUR supplementation in
piglets, challenged by Escherichia coli, improved intestinal mucosal bar-
rier integrity by decreasing the inflammatory cytokines. In addition,
Bible (2013) showed that an 80 mg/kg diet of CUR significantly
decreased the serum concentrations of TNF-α and APPs under LPS chal-
lenge in nursery pigs, which contrasted the present data. It seems that, in
a context of APR, the effect of CUR on cytokines and APPs concentrations
in ruminants is not similar to other animal species.
Also, regarding FO, the present findings are consistent with those
studies that have investigated this supplement in ruminants. Indeed, in
the study of McDonnell et al. (2019), it was evidenced that 40 g FO per
day did not affect the calves’ immune function. They did not report any
effect of FO on Hp and IFN-γ and other hematology variables. However,
Karcher et al. (2014) reported that using 2% FO in the milk replacer (MR)
of calves tended to reduce the expression of TNF-α and IL-8 (P < 0.1), in
an in vitro LPS challenge experiment (2 μg/ml LPS), which is contradicted
by the present results. Ballou et al. (2008) supplemented 2% FO in MR of
Jersey calves and found that the concentration of glucose, insulin, BUN,Figure 3. Effects of fish oil and nanocurcumin vs.
dexamethasone on the three behavior phases in
Holstein calves after LPS challenge based on the
model of Plessers et al. (2015b). The boxes
illustrate the mean period of the different phases,
while the vertical lines indicate the minimum and
maximum points in time when the respective
phase starts and ends, regarding a certain animal.
The beginning and the end of the respiratory
phase is determined by the onset of dyspnoea and
recovery from respiratory distress, respectively.
Recovery from respiratory distress also indicates
the start of the depression phase. This phase ends
when alertness is regained, which confirms
initiation of the recovery phase. When the animal
stands up the end of recovery phase is assumed,
indicating full recovery of the calf.
Figure 4. Effects of fish oil and nanocurcumin vs. dexamethasone on TNF-⍺ (A), IL-6 (B), Hp (C), and SAA (D) in Holstein calves after LPS challenge. Data is shown as
mean þ SD. The different letters within each time (T) indicate a significant difference between groups (P < 0.05).
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of Salmonella Typhimurium LPS challenge. Although, in their experi-
ment the inflammatory cytokines and APPs were not evaluated, they
concluded that FO attenuates biochemical aspects of the acute phase
response in Jersey calves. The insignificant effects of FO and NCUR on
inflammatory cytokines and APPs in the current study, compared to the
literature, could be attributed to the differences in experimental design,
types of LPS challenge model, types of animal, and calf age.
Another important factor to consider is sickness behavior and its most
prominent drivers. The observed fever that follows LPS challenge is
considered to be mediated by the action of prostaglandin E2, TNF-α, IL-
1ß, and IL-6 (Roth and Blatteis, 2011). Moreover, it has been explained
that TNF-⍺ is the primary mediator of acute inflammation in response to
Gram-negative bacteria, which enhances the production of other
pro-inflammatory cytokines such as IL-6 (Conti, 2004). In addition,
sickness behavior is also associated with cytokine activation (Brymer
et al., 2019). Studies have confirmed that IL-6 is positively associated
with the incidence and severity of depression (Howren et al., 2009). In
this research, the levels of TNF-⍺ and IL-6 significantly increased after
LPS administration, which is in line with previous work (Carroll et al.,
2009; Plessers et al., 2015a, 2015b; Fernandes et al., 2019). In the pre-
sent study, DEX did not exert any effect on respiratory distress and fever
development but, as expected, had a definite positive influence on
depression and recovery phases (Figure 3). The absence of a depression
phase in DEX agrees with Plessers et al. (2015a), supporting that inhib-
iting inflammatory cytokines could positively affect sickness behavior in
calves.
One of the most remarkable results of this study was that natural anti-
inflammatory compounds did not have any significant effect on sickness
behavior in LPS challenged calves (Figure 3). The insignificant effects of
FO and NCUR groups vs. LPS group on sickness behavior might be related
to the concentration of TNF-⍺ and IL-6, for which no differences were
observed between these groups (Figure 4). An alleviated sickness
behavior has been reported in calves fed FO (Ballou et al., 2008) and in
pigs fed CUR (Bible, 2013). However, in Ballou et al. (2008), FO had no
significant effect on appetite which is in line with the present study.
Beside cytokines, sickness behavior can also be regulated by other factors
such as eicosanoids, peripheral signals, and neurotransmitters. However,
the effect of FO and CUR on these factors following the LPS challenge in
calves has not been assessed.
In this experiment, it was expected that groups with lower cytokines
concentrations would exhibit higher ADG. However, the results showed6
that DEX vs. LPS could not significantly increase ADG during three days
p.c. (Figure 5). In normal physiological states, the immune system is only
active to a limited extent and needs little energy and nutrients. Through
infection, the immune system is strongly activated, which causes changes
in nutrient partitioning and growth (Kinsbergen et al., 1994). The APR
causes anorexia, which limits nutrient availability and reduces growth.
Moreover, in the APR, the concentrations of cytokines increase signifi-
cantly, and because the inflammatory cytokines act locally and system-
ically to regulate energy metabolism, this could affect body weight loss
(Wang and Ye, 2015). Cytokines act in the brain, fat, and muscle tissues
in a systemic process to regulate energy metabolism. In the brain, they
inhibit energy input through suppression of appetite, which means in-
hibition of the hypothalamus. Consequently, the host has to use the en-
ergy stores in adipose tissue and skeletal muscle to satisfy the energy
demands from the immune systems (Wang and Ye, 2015). In this regard,
studies reported that TNF and IL-6 play a vital role in mobilizing body
stores of energy which are necessary to fight infection (Molloy et al.,
1993; Wang and Ye, 2015). This could explain why there were no sig-
nificant differences in ADG between DEX and LPS during three days p.c.,
as there might be a higher energy demand to produce cytokines even in
low amount in APR in DEX group. In the current study, there was no
effect of natural anti-inflammatory compounds on ADG during three days
p.c. compared to the LPS group, which might be related to the insignif-
icant difference in TNF-⍺ and IL-6 levels. This result rebuts Bible (2013),
who reported that CUR was able to limit body weight loss in LPS chal-
lenged pigs. On the other hand, this research is in line with Karcher et al.
(2014), who stated that FO did not have a significant effect on ADG.
However, the lack of any significant effects on ADG between groups
might be related to the sample size (6 replicates per group). Future
research needs to be undertaken to explain the effect of FO and CUR on
body weight recovery in LPS challenged calves, more than three days p.c.
and with a higher sample size.
Regarding the second hypothesis, it was investigated that whether FO
and NCUR could serve as an alternative to glucocorticoids in order to
decrease the high usage of synthetic drugs to treat calves’ diseases.
Although previous studies in non ruminants reported similar anti-
inflammatory mechanisms for FO, CUR, and DEX through the reduc-
tion of NF-κB transcription (Rhen and Cidlowski, 2005; Calder, 2013;
Prasad et al., 2014), the present data were not able to reveal similar ef-
fects from FO and NCUR on APR in calves compared to glucocorticoids.
Therefore, the data with regard to the cytokines, APPs, and sickness
behavior were rejective towards the hypothesis. It has been evidenced
Figure 5. Effects of fish oil and nanocurcumin vs. dexamethasone on DMI and
ADG in Holstein calves following three days post LPS challenge. Data is shown
as mean  SD.
S. Kamel Oroumieh et al. Heliyon 7 (2021) e05894that glucocorticoids can prevent inflammation by three independent
mechanisms: (1) the induction and activation of annexin I, (2) the in-
duction of MAPK phosphatase 1, and (3) the repression of transcription of
NF-κB (Rhen and Cidlowski, 2005). With this rationale, we propose two
reasons why protective effects from FO and CUR were not observed with
respect to the deleterious effects of APR. First, the significant effects of
DEX on cytokines could be related to other anti-inflammatory mecha-
nisms compared with those described for FO and CUR. Secondly,
although this study did not evaluate the anti-inflammatory mechanism(s)
in detail, it seems that the effect of FO and CUR on the transcription of
NF-κB might not be as severe in ruminants as in other animals such as
pigs. Future studies, which evaluate the effect of FO and CUR on the
transcription of NF-κB in APR in ruminants, are required.
This paper was the first study to evaluate the effect of NCUR in
response to an LPS challenge in calves, also, it was the first report which
compared FO and NCUR vs. DEX under LPS challenge in ruminants. We
believe that the response of calves to CUR is not completely clear yet, for
which more research is designated with respect to both calves’ health
status and performance.
An important limitation within the current study was the sample size,
which appeared to be rather low to accurately assess the immune re-
sponses that were found highly variable across the animals. Although the
number of animals per treatment group was based on the similar work of
Charan and Kantharia (2013) and Ohtsuka et al. (1997), 6 or 5 replicates
turned out to be insufficient to generalize the effects of the CAM treat-
ments on APR in calves. Repeated sampling and data recording at specific
times and intensive care of challenged calves, were some of the current
study's practical difficulties. Also, the experimental costs and a large
number of treatments were assigned as another limitation, which led to a
decrease in the number of repeats per group. It is recommended to in-
crease the power by decreasing the number of experimental groups in
future studies. Moreover, future studies on the current topic are therefore7
recommended: to identify the appropriate doses of FO and CUR as
anti-inflammatory compound in APR in calves; to evaluate the effects of
FO and CUR (separately or as a mixture of them) on the NF-κB tran-
scription in APR in calves; and subsequently, to evaluate the effect of
CAM in combination with different doses of anti-inflammatory drugs on
APR in calves.
5. Conclusions
The results from this study suggested that FO and NCUR could not
protect calves from the deleterious effects of excessive APR. Indeed,
usage of these natural anti-inflammatory compounds could not prevent
the increase of inflammatory cytokines and APPs levels, as being pro-
voked by endotoxin challenge in calves. Related to this, no beneficial
effects on sickness behavior, DMI and ADG in LPS challenged calves were
observed. In general, these findings may suggest that the effect of FO and
CUR on NF-κB transcription in ruminants is different compared to other
animals, especially pigs. The present study confirms that dexamethasone
treatment improves recovery and anti-inflammatory response in calves. It
is also relevant to note that the present experiment was limited by small
sample size (n ¼ 6 per treatment). Therefore, a larger number of treat-
ment replicates is strongly suggested to further assess the underlying
mechanisms of natural anti-inflammatory compounds (e.g. their impact
on NF-κB transcription) and evaluate their potential in combination with
low doses of drugs.
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